Gyre Therapeutics, Inc. GYRE Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s pre-tax income?
- Gyre Therapeutics, Inc. (GYRE) reported pre-tax income of -$9.24M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s pre-tax income changed year-over-year?
- Gyre Therapeutics, Inc.'s pre-tax income decreased by 299.3% year-over-year, from $4.64M to -$9.24M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s pre-tax income?
- Over 3 years (2021 to 2025), Gyre Therapeutics, Inc.'s pre-tax income has grown at a -45.2% compound annual growth rate (CAGR), from -$87.93M to $14.5M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.